Richard Mac Leod
About Richard Mac Leod
Richard Mac Leod serves as the Executive Director of Clinical Operations at Inozyme Pharma, bringing extensive experience from previous roles at Ora, Inc. and X4 Pharmaceuticals, where he held various positions in clinical operations over several years.
Current Role at Inozyme Pharma
Richard Mac Leod serves as the Executive Director of Clinical Operations at Inozyme Pharma. He has held this position since 2024, contributing to the company's clinical initiatives and operational strategies. His role involves overseeing clinical trials and ensuring compliance with regulatory standards.
Previous Experience at X4 Pharmaceuticals
Prior to his current role, Richard Mac Leod worked at X4 Pharmaceuticals in various capacities. He served as Associate Director of Clinical Operations from 2020 to 2021 and later as Director of Clinical Operations from 2022 to 2024. His responsibilities included managing clinical trial operations and leading teams to achieve project goals.
Career at Ora, Inc.
Richard Mac Leod has extensive experience at Ora, Inc., where he held multiple positions from 2015 to 2020. He began as a Lead Senior Site Operations Associate, then progressed to Assistant Manager of Operations, and later served as Associate Director. His tenure at Ora, Inc. involved significant contributions to site operations and management.
Educational Background
Richard Mac Leod earned a Bachelor of Applied Science (B.A.Sc.) degree in Biology from Trinity College-Hartford, where he studied from 2007 to 2011. During his time at Trinity College, he also worked as a Research Associate in Biology, gaining valuable research experience.